Korean Association for the Study of Intestinal Diseases guidance for clinical practice of adult inflammatory bowel disease during the coronavirus disease 2019 pandemic: expert consensus statements

Yong Eun Park; Yoo Jin Lee; Ji Young Chang; Hyun Joo Song; Duk Hwan Kim; Young Joo Yang; Byung Chang Kim; Jae Gon Lee; Hee Chan Yang; Miyoung Choi; Seong-Eun Kim; Seung-Jae Myung

doi:10.5217/ir.2021.00111

Korean Association for the Study of Intestinal Diseases guidance for clinical practice of adult inflammatory bowel disease during the coronavirus disease 2019 pandemic: expert consensus statements

Intest Res. 2022 Oct;20(4):431-444. doi: 10.5217/ir.2021.00111. Epub 2022 Jan 5.

Authors

Yong Eun Park¹, Yoo Jin Lee², Ji Young Chang³, Hyun Joo Song⁴, Duk Hwan Kim⁵, Young Joo Yang⁶, Byung Chang Kim⁷, Jae Gon Lee⁸, Hee Chan Yang⁹, Miyoung Choi¹⁰, Seong-Eun Kim¹¹, Seung-Jae Myung¹²

Affiliations

¹ Division of Gastroenterology, Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.
² Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea.
³ Health Promotion Center, Ewha Womans University Seoul Hospital, Seoul, Korea.
⁴ Department of Internal Medicine, Jeju National University College of Medicine, Jeju, Korea.
⁵ Digestive Disease Center, CHA Bundang Medical Center, CHA University, Seongnam, Korea.
⁶ Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.
⁷ Center for Colorectal Cancer, National Cancer Center, Goyang, Korea.
⁸ Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Korea.
⁹ Division of Gastroenterology and Hepatology Department of Internal Medicine, Jeonbuk National University Medical School, Jeonju, Korea.
¹⁰ Division of Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Seoul, Korea.
¹¹ Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea.
¹² Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Abstract

Many unexpected problems have resulted from the unprecedented coronavirus disease 2019 (COVID-19) pandemic. The optimal management of patients with inflammatory bowel disease (IBD) during the COVID-19 pandemic has also been a challenge. Therefore, the Korean Association for the Study of Intestinal Diseases (KASID) developed a consensus statement of experts regarding the management of IBD during the COVID-19 pandemic. This consensus statement made recommendations regarding the risk and treatment of COVID-19 in IBD patients. This statement emphasizes that IBD is not a risk factor for COVID-19, and care should be taken not to exacerbate IBD in patients in remission state by maintaining their medications, except for corticosteroids.

Keywords: COVID-19; Inflammatory bowel disease; Management; SARS-CoV-2.